FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / opposition-motion-to-dismiss.docx
opposition-motion-to-dismiss.docx · 1013-00005

Parties

Plaintiff Genome Dx Therapeutics Inc
HARKNESS LLP
Alice Corp
Rapid Litigation Management Ltd
Vanda Pharmaceuticals Inc
West-Ward Pharmaceuticals International Ltd
Int'l Ltd
HP Inc

Dates

November 3, 2025
September 15, 2025
August 4, 2025
September 18, 2026
August 15, 2024
March 22, 2019
December 21, 2021
June 14, 2036
September 9, 2021
February 6, 2024

Amounts

$275
$387.6
$3,820
$32,088,000

Obligations

Rule 12(b)(6) Standard Under Federal Rule of Civil Procedure 12(b)(6), a complaint must be dismissed only if it fails to state a claim upon which relief can be granted
To survive a motion to dismiss, a complaint must contain "sufficient factual matter, accepted as true, to 'state a claim to relief that is plausible on its face
In evaluating a motion to dismiss, the Court must accept all well-pleaded factual allegations in the complaint as true and draw all reasonable inferences in the plaintiff's favor
175, 188 (1981) ("In determining the eligibility of respondents' claimed process for patent protection under § 101, their claims must be considered as a whole
The Supreme Court has cautioned that "all inventions at some level embody, use, reflect, rest upon, or apply laws of nature, natural phenomena, or abstract ideas," and that the § 101 inquiry must therefore be conducted at an appropriate level of generality
These allegations must be accepted as true at the 12(b)(6) stage